This contract involves the periodic supply of pharmaceutical products, specifically anticancer and immunomodulating medications, to the University Specialized Hospital for Active Treatment of Oncology "Prof. Ivan Chernozemsky" EAD. The procurement is divided into 103 specific categories, with detail
Contract awarded. Originally published 7 months ago.
No single supplier dominates the field.
In healthcare medical, UNIVERSITY SPECIALIZED HOSPITAL FOR ACTIVE TREATMENT IN ONCOLOGY "PROF. IVAN CHERNOZEMSKI" PLC has awarded 3 contracts to 3 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the periodic delivery of pharmaceutical products based on prior requests for the needs of the Specialized Hospital for Active Treatment in Oncology "Prof. Ivan Chernozemsky" EAD. The procurement is divided into 46 specific categories. The required pharmaceutical products are d
This public procurement contract is for selecting a supplier to deliver disinfectants to the University Specialized Hospital for Active Treatment of Oncology "Prof. Ivan Chernozemski" EAD in Sofia, Bulgaria, for a duration of 24 months. The contract includes periodic deliveries based on monthly requ
This procurement contract is for the supply of consumables and reagents needed by the Clinical Laboratory, Microbiology Laboratory, and Transfusion Hematology Laboratory at the University Specialized Hospital for Active Treatment of Oncology "Prof. Ivan Chernozemski" EAD. The contract includes perio
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
